Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions.
Griffioen AW, Relou IA, Gallardo Torres HI, Damen CA, Martinotti S, De Graaf JC, Zwaginga JJ, Groenewegen G.
Angiogenesis. 1998;2(3):235-43.
Similar articles
IgA and the IgA Fc receptor.
van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG.
Trends Immunol. 2001 Apr;22(4):205-11. Review.
FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, van Hattum J, Kuiper J, van de Winkel JG.
Nat Med. 2000 Jun;6(6):680-5.
Resolution of cutaneous inflammation after local elimination of macrophages.
Thepen T, van Vuuren AJ, Kiekens RC, Damen CA, Vooijs WC, van De Winkel JG.
Nat Biotechnol. 2000 Jan;18(1):48-51.
In vitro upregulation of carcinoembryonic antigen expression by combinations of cytokines.
Verhaar MJ, Damen CA, Zonnenberg BA, Blijham GH.
Cancer Lett. 1999 May 3;139(1):67-73.
Angiogenesis inhibitors overcome tumor induced endothelial cell anergy.
Griffioen AW, Damen CA, Mayo KH, Barendsz-Janson AF, Martinotti S, Blijham GH, Groenewegen G.
Int J Cancer. 1999 Jan 18;80(2):315-9.
Effect of culture conditions on endothelial cell growth and responsiveness.
Relou IA, Damen CA, van der Schaft DW, Groenewegen G, Griffioen AW.
Tissue Cell. 1998 Oct;30(5):525-30.
Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors.
Hellwig SM, Damen CA, van Adrichem NP, Blijham GH, Groenewegen G, Griffioen AW.
Cancer Lett. 1997 Dec 9;120(2):203-11.
CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells.
Griffioen AW, Coenen MJ, Damen CA, Hellwig SM, van Weering DH, Vooys W, Blijham GH, Groenewegen G.
Blood. 1997 Aug 1;90(3):1150-9.
Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium.
Griffioen AW, Damen CA, Blijham GH, Groenewegen G.
Blood. 1996 Jul 15;88(2):667-73.
In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts.
van der Veen MJ, Scheven BA, van Roy JL, Damen CA, Lafeber FP, Bijlsma JW.
Br J Rheumatol. 1996 Apr;35(4):342-9.
Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors.
Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G.
Cancer Res. 1996 Mar 1;56(5):1111-17.
Endoglin/CD 105 may not be an optimal tumor endothelial treatment target.
Breast Cancer Res Treat. 1996;39(2):239-42. No abstract available.
Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA, van der Veen MJ, Damen CA, Lafeber FP, Van Rijn HJ, Bijlsma JW, Duursma SA.
J Bone Miner Res. 1995 Jun;10(6):874-80.
Comparison of the action of 17 beta-estradiol and progestins with insulin-like growth factors-I/-II and transforming growth factor-beta 1 on the growth of normal adult human bone-forming cells.
Verhaar HJ, Damen CA, Duursma SA, Scheven BA.
Maturitas. 1995 Apr;21(3):237-43.
A comparison of the action of progestins and estrogen on the growth and differentiation of normal adult human osteoblast-like cells in vitro.
Bone. 1994 May-Jun;15(3):307-11.
Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro.
Scheven BA, Damen CA, Hamilton NJ, Verhaar HJ, Duursma SA.
Biochem Biophys Res Commun. 1992 Jul 15;186(1):54-60.
Filters: Manage Filters